Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,049 public trials 570 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma

NCT01794520

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic - Scottsdale /ID# 75808 Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 170002 Little Rock, Arkansas, United States
  • Yale University /ID# 203704 New Haven, Connecticut, United States
  • Emory University, Winship Cancer Institute /ID# 74993 Atlanta, Georgia, United States
View all 29 locations
View Trial Details
Completed

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

NCT02726581

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 0020 Birmingham, Alabama, United States
  • Local Institution - 0160 Mobile, Alabama, United States
  • Local Institution - 0163 Fayetteville, Arkansas, United States
  • Local Institution - 0118 Bakersfield, California, United States
View all 121 locations
View Trial Details
Completed

A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

NCT01564537

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • University of Arkansas Medical Sciences Little Rock, Arkansas, United States
  • Pacific Cancer Medical Center Inc Anaheim, California, United States
  • West Contra Costa Healthcare District Berkeley, California, United States
  • University of Florida Gainesville, Florida, United States
View all 24 locations
View Trial Details
Completed

A Registry Study of Participants With Multiple Myeloma in Latin America

NCT03955900

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Fundaleu Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires Buenos Aires, Argentina
  • Instituto de Oncologia Angel H. Roffo Buenos Aires, Argentina
  • Hospital Privado - Centro Medico de Cordoba Córdoba, Argentina
View all 22 locations
View Trial Details
Completed

A Study of Cobimetinib Administered as Single Agent and in Combination With Venetoclax, With or Without Atezolizumab, in Participants With Relapsed and Refractory Multiple Myeloma

NCT03312530

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Fakultni nemocnice Brno; Interni hematologicka a onkologicka klinika Brno, Czechia
  • Fakultni nemocnice Ostrava; Klinika hematoonkologie Ostrava, Czechia
  • Univerzita Karlova v Praze a Vseobecna fakultni nemocnice v Praze - 1; Lekarska Fakulta - I Prague, Czechia
  • Rigshospitalet; Hæmatologisk Klinik København Ø, Denmark
View all 26 locations
View Trial Details

Related conditions